Biosig sees increased case volume from expanding base of medical centers using its proprietary signal processing system

Westport, ct, may 04, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that it increased the patient case goal from 1000 to at least 1500 procedures by the end of 2021.
BSGM Ratings Summary
BSGM Quant Ranking